Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results.
Doris LeithnerJoao V HorvatMaria Adele MarinoBlanca Bernard-DavilaMaxine S JochelsonR Elena Ochoa-AlbizteguiDanny F MartinezElizabeth A MorrisSunitha ThakurPinker KatjaPublished in: Breast cancer research : BCR (2019)
In this preliminary study, radiomic signatures with CE-MRI enable the assessment of breast cancer receptor status and molecular subtypes with high diagnostic accuracy. These results need to be confirmed in future larger studies.